EMA starts evaluation of Moderna's booster application
![Photo: David W Cerny/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13322279.ece/ALTERNATES/schema-16_9/20210924-161829-2-1920x1078we.jpg)
The European Medicines Agency (EMA) has begun its assessment of data from US-based Moderna, which has applied for the approval of its Spikevax in use as a Covid-19 booster vaccine, the EMA reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
EMA begins assessment of Pfizer booster application
For subscribers
Sanofi pivots toward boosters after Covid vaccine delays
For subscribers